Idorsia's Fabry Drug Founders In Phase III

Lucerastat Fails To Reduce Neuropathic Pain

 
• By Kevin Grogan
  
Idorsia building
Setback for Swiss biotech • Source: Idorsia
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D